Notably, combination of CNOT4 overexpression and anti‐PD‐1 treatment dramatically inhibited tumor growth, suggesting that CNOT4 overexpression enhanced the effect of anti‐PD‐1 immunotherapy in lung cancer. Here, CNOT4 is linked to neoplasm.